Glioblastoma is one of the most lethal diagnoses in medicine. Even with surgery, radiation therapy, and chemotherapy, most patients survive less than 15 months. One fundamental reason is the blood-brain barrier, a protective biological system that blocks most drugs from reaching the brain at therapeutic concentrations.
A newly published study in Oncoscience describes a potential strategy for bypassing that barrier: use vitamin B12 as a molecular carrier.
-copy-29e15046.jpeg?w=600)
